Metropolitan Life Insurance Company (MetLife)’s Integral Ad Science IAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,636
Closed -$36.3K 996
2024
Q1
$36.3K Buy
3,636
+789
+28% +$10.5K ﹤0.01% 1566
2023
Q4
$41K Hold
2,847
﹤0.01% 1551
2023
Q3
$33.9K Buy
2,847
+617
+28% +$9.54K ﹤0.01% 1612
2023
Q2
$40.1K Hold
2,230
﹤0.01% 1562
2023
Q1
$31.8K Sell
2,230
-267
-11% -$3K ﹤0.01% 1638
2022
Q4
$21.9K Buy
2,497
+182
+8% +$1.54K ﹤0.01% 1967
2022
Q3
$16.8K Hold
2,315
﹤0.01% 2108
2022
Q2
$23K Hold
2,315
﹤0.01% 1983
2022
Q1
$31.9K Sell
2,315
-2,924
-56% -$49.8K ﹤0.01% 1847
2021
Q4
$116K Hold
5,239
﹤0.01% 2383
2021
Q3
$108K Buy
+5,239
New +$103K ﹤0.01% 2482

Other funds holding IAS

Metropolitan Life Insurance Company (MetLife)'s IAS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Integral Ad Science (IAS) in Q2 2024, closing a stake of 3,636 shares — an estimated $36.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IAS in Q3 2021 and held it in 11 quarters. The position peaked at $116K in Q4 2021. 155 funds tracked by Wall St. Rank hold IAS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Integral Ad Science position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,636 Integral Ad Science shares in Q2 2024, an estimated $36.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Integral Ad Science in Q3 2021 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Integral Ad Science position peaked at $116K in Q4 2021.
  • 155 funds tracked by Wall St. Rank held Integral Ad Science as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.